Search Results - Ehrisman, J.A.

  • Showing 1 - 9 results of 9
Refine Results
  1. 1
    Patient, caregiver and physician perceptions of palliative care in ovarian cancer: Insights from the HOPE prospective pilot study

    Patient, caregiver and physician perceptions of palliative care in ovarian cancer: Insights from the HOPE prospective pilot study by Lee, P.S, Bloom, D, Ehrisman, J.A, Havrilesky, L.J, Secord, A.A, Bae-Jump, V.L, Tulsky, J.A

    Published in Gynecologic oncology
    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    A prospective study of intraoperative uterine assessment in low-grade endometrial cancer

    A prospective study of intraoperative uterine assessment in low-grade endometrial cancer by Puechl, A.M, Ehrisman, J.A, Secord, A.A, Valea, F.A, Berchuck, A, Havrilesky, L.J, Lee, P.S

    Published in Gynecologic oncology
    Get full text
    Article
    Save to List
    Saved in:
  3. 3
    Sentinel lymph node mapping in women with high risk histology endometrial cancer

    Sentinel lymph node mapping in women with high risk histology endometrial cancer by Ehrisman, J.A, Secord, A.A, Berchuck, A, Lee, P.S, Di Santo, N, Valea, F.A, Havrilesky, L.J

    Published in Gynecologic oncology
    Get full text
    Article
    Save to List
    Saved in:
  4. 4
    PNS232 ARE VIDEOS OR TEXT BETTER FOR DESCRIBING ATTRIBUTES IN STATED-PREFERENCE SURVEYS? SOME EXPERTS WILL BE SURPRISED

    PNS232 ARE VIDEOS OR TEXT BETTER FOR DESCRIBING ATTRIBUTES IN STATED-PREFERENCE SURVEYS? SOME EXPERTS WILL BE SURPRISED by Reed, S., Yang, J.C., Ehrisman, J.A., Lim, S.L., Havrilesky, L.J.

    Published in Value in health
    Get full text
    Article
    Save to List
    Saved in:
  5. 5
    Rate of venous thromboembolism during neoadjuvant chemotherapy for advanced ovarian cancer

    Rate of venous thromboembolism during neoadjuvant chemotherapy for advanced ovarian cancer by Salinaro, J.R., Boccaccio, R.B., Ehrisman, J.A., Havrilesky, L.J., Secord, A.A., Moore, K.N., Davidson, B.A.

    Published in Gynecologic oncology
    Get full text
    Article
    Save to List
    Saved in:
  6. 6
    Bevacizumab, TKI, or PARPi? A targeted approach using composite value-based endpoints and biomarkers to individualize care for platinum-sensitive recurrent ovarian cancer (PSROC)

    Bevacizumab, TKI, or PARPi? A targeted approach using composite value-based endpoints and biomarkers to individualize care for platinum-sensitive recurrent ovarian cancer (PSROC) by Foote, J.R., Alvarez-Secord, A., Liang, M.I., Ehrisman, J.A., Cohn, D.E., Jewell, E., Havrilesky, L.J.

    Published in Gynecologic oncology
    Get full text
    Article
    Save to List
    Saved in:
  7. 7
    Association between isolated tumor cells and recurrence in stage I endometrial cancer

    Association between isolated tumor cells and recurrence in stage I endometrial cancer by Puechl, A.M., Strickland, K.C., Tanner, E.J., Murdock, T., Broadwater, G., Ehrisman, J.A., Lee, P.S., Secord, A.A., Havrilesky, L.

    Published in Gynecologic oncology
    Get full text
    Article
    Save to List
    Saved in:
  8. 8
    PCN532 WOMEN'S PREFERENCES ON BENEFITS, RISKS, AND SIDE EFFECTS OF MAINTENANCE PARP INHIBITOR THERAPY IN OVARIAN CANCER

    PCN532 WOMEN'S PREFERENCES ON BENEFITS, RISKS, AND SIDE EFFECTS OF MAINTENANCE PARP INHIBITOR THERAPY IN OVARIAN CANCER by Havrilesky, L.J., Lim, S.L., Ehrisman, J.A., Lorenzo, A., Alvarez Secord, A., Yang, J.C., Johnson, F.R., Reed, S.D.

    Published in Value in health
    Get full text
    Article
    Save to List
    Saved in:
  9. 9
    Do patients care who is paying for their ovarian cancer treatment? Patient perspectives on value-based assessments

    Do patients care who is paying for their ovarian cancer treatment? Patient perspectives on value-based assessments by Foote, J.R., Alvarez-Secord, A., Liang, M.I., Ehrisman, J.A., Wu, M., Cohn, D.E., Jewell, E., Havrilesky, L.J.

    Published in Gynecologic oncology
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: